ALS patients who receive a tracheostomy live a median of about 47 months (roughly 4 years) from symptom onset, compared to 31 months for those who do not. That difference of about 16 months represents a meaningful extension, though individual outcomes vary widely depending on age, the type of ALS, nutritional status, and the level of care available at home.
Survival After Tracheostomy by the Numbers
A study analyzing survival with Kaplan-Meier curves found that tracheostomy with mechanical ventilation extended median survival to 47 months from symptom onset, versus 31 months for patients without tracheostomy. The benefit was even more pronounced in younger patients: those under 60 at symptom onset survived a median of 57.5 months with a tracheostomy, compared to 38.5 months without one. That’s nearly a 19-month gain for younger patients, versus a smaller but still meaningful gain for older ones.
Some patients live far longer than those medians suggest. Case reports and clinical series describe patients surviving 10 years or more on invasive ventilation. These tend to be younger individuals with spinal-onset disease and strong support systems. On the other end, patients who are older at onset or who already have significant bulbar symptoms may see a shorter extension of life.
Factors That Influence How Long You Live
Age at symptom onset is one of the strongest predictors. Patients whose symptoms start before age 40 often survive more than 10 years overall, while those diagnosed after 80 typically live less than two years regardless of interventions. A tracheostomy shifts the curve, but it doesn’t erase the influence of age.
Where ALS starts in the body also matters. Bulbar-onset disease, which first affects speech and swallowing, carries a worse prognosis than spinal-onset disease, which begins in the limbs. This isn’t simply because bulbar onset is more common in older patients. Bulbar involvement at any stage independently worsens outcomes, likely because it complicates airway management and nutrition.
Nutritional status plays a larger role than many people realize. A low body mass index (below 18.5) is an independent risk factor for shorter survival. Weight loss before or after tracheostomy signals faster disease progression. Maintaining caloric intake, often through a feeding tube placed alongside or before the tracheostomy, is one of the few modifiable factors that can influence the timeline.
Quality of Life After the Procedure
One concern families often have is whether survival after tracheostomy comes at the cost of meaningful quality of life. The data here is more reassuring than many expect. In a study of 13 ALS patients living with a tracheostomy, their average quality-of-life scores were essentially identical to those of ALS patients without a tracheostomy and comparable to the general population. Only 15% of the tracheostomized patients met criteria for severe depression. Most strikingly, 11 of the 13 patients said they would choose the tracheostomy again if given the decision a second time.
That said, quality of life depends heavily on circumstances. Patients who planned the tracheostomy in advance and had caregiving infrastructure in place tended to fare better emotionally than those who received one on an emergency basis. Emergency tracheostomies, performed during a respiratory crisis, sometimes happen against a patient’s previously expressed wishes, which can create lasting distress for both the patient and their family.
The Reality of Daily Care
Living at home with a tracheostomy and ventilator requires substantial daily care. About half of caregivers in one study provided fewer than four hours of hands-on care per day, but the other half provided more, and the total burden extends well beyond those hours. Caregivers manage suctioning, cleaning the outer cannula, administering nebulizer treatments, monitoring the ventilator, and often providing oxygen therapy. Each of these tasks adds measurably to caregiver stress.
Caregiver burden scores in that study averaged in the moderate range, and burden increased significantly with more daily care hours. Families considering this path should realistically assess whether they can sustain round-the-clock or near-round-the-clock support for years. In many cases, this means hiring home health aides or nursing staff in addition to family involvement. The financial and emotional cost of this support is one of the primary reasons tracheostomy rates vary so dramatically between countries and even between families.
Why Tracheostomy Rates Differ Around the World
In Japan, a much higher percentage of ALS patients receive tracheostomies compared to the United States. A survey of caregivers found that 53% of Japanese caregivers favored invasive ventilation for their family member, compared to 33% of American caregivers. Only 10% of Japanese caregivers were opposed, versus 22% of American caregivers. Cultural attitudes toward life prolongation, differences in healthcare coverage, and family structure all contribute to these gaps.
In many Western countries, the conversation around tracheostomy in ALS is framed partly around the concept of “ventilator entrapment,” the concern that once a patient is on permanent ventilation, discontinuing it becomes emotionally and ethically complex. This concern is real. As the disease progresses, patients may lose the ability to communicate their wishes entirely, reaching a locked-in state where they are fully conscious but unable to speak, move, or signal. Establishing clear advance directives before that point is critical for ensuring the patient’s preferences are honored.
Planned vs. Emergency Tracheostomy
The circumstances under which the tracheostomy happens make a significant difference in outcomes and satisfaction. A planned tracheostomy, discussed in advance with the patient, family, and care team, allows everyone to prepare the home environment, arrange caregiving, and set expectations. Patients who go through this process tend to report higher satisfaction and better psychological adjustment.
Emergency tracheostomies are more common than ideal. When a patient goes into acute respiratory failure without prior planning, the medical team may perform a tracheostomy as a life-saving measure, sometimes without knowing the patient’s wishes. In one documented case in Korea, a patient who had repeatedly asked for life-sustaining treatment to be withheld received an emergency tracheostomy after cardiac arrest because no formal documentation existed. The ventilation was later withdrawn in accordance with her wishes, but only after a prolonged and painful process for the family. This scenario underscores why having written advance directives matters, especially for a disease with a predictable trajectory like ALS.
What Causes Death After Tracheostomy
Without a tracheostomy, the most common cause of death in ALS is respiratory failure, typically within two to five years of onset. A tracheostomy removes that particular endpoint by mechanically handling breathing. For ventilated patients, the causes of death shift. Pneumonia and other respiratory infections become a primary risk because the tracheostomy tube bypasses the body’s natural airway defenses. Cardiovascular events, sepsis, and complications related to immobility also contribute. Progressive loss of all voluntary muscle function, including the ability to swallow secretions, creates ongoing infection risk that even excellent care cannot fully eliminate.